Nickel release after implantation of the amplatzer occluder
Nickel release after implantation of the amplatzer occluder
复制标题
DOI:
10.1067/mhj.2003.7
复制
发表时间:
2003-04-01
影响因子:
4.8
通讯作者:
Meyer, J
中科院分区:
文献类型:
--
作者:
Ries, MW;Kampmann, C;Meyer, J
Background Transcatheter closure of atrial septal defects is a new and less traumatic technique than open heart surgery. In recent years, patients with a patent foramen ovale sustaining potential paradoxical embolism have also, become candidates for interventional closure devices. One of the more popular occluding devices is the Amplatzer septal occluder, which, like many other occluders, is made of nitinol. Nitinol-based alloys are widely used in medical products, for example, in orthopedics and orthodontics. However, the clinical use of nitinol, which contains 55% nickel, is still controversial because of concerns about its biocompatibility. Therefore, we examined the systemic nickel release after implantation of the Amplatzer occluder.Methods and Results In 67 patients with no history of nickel sensitivity, blood samples were taken 24 hours before and 24 hours, 1, 3, and 12 months after occluder implantation. Nickel serum concentrations were measured by atomic absorption spectrometry; a value of